SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 83.58+1.8%Nov 26 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (2190)2/26/2008 10:01:51 AM
From: Jibacoa  Read Replies (1) of 3722
 
CGPI opened with an UG & is up 27.97% on volume of 2,941,866 > 14x its ADV

The stock has appreciated 400% since Dec 1

bigcharts.marketwatch.com

It announced a definitive agreement to be acquired by Galderma' Laboratories at a price of $16.60 in cash.

CGPI had launched Oracea,approved by the FDA for treatment of rosacea, in 2006 & is developing Col-118 for the erythema associated with rosacea.It is also working on a product that could provide added benefits for the treatment of psoriasis.

The $16.60 is the highest price for CGPI since 2003

bigcharts.marketwatch.com

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext